Health ❯ Medicine

Clinical Trials

Drug Development Phase 3 Trials Drug Approval Drug Efficacy Cancer Treatment Patient Care Research Studies Preclinical Studies Cancer Research Drug Testing

Daraxonrasib Doubles Survival in Phase 3 Trial of Treated Metastatic Pancreatic Cancer

An oral KRAS inhibitor that raised median survival to 13.2 months is now available through an FDA expanded access program pending formal review

Study Links Two Weather Patterns to Higher Headache Risk

Personalized mRNA Vaccine Halves Five‑Year Melanoma Recurrence Risk

Tumor Inflammation Drives Early Resistance to KRAS Drugs, Study Shows

Asthma Drug Montelukast Restores Checkpoint Response in Preclinical Cancer Models

Real-World Study Finds Tezepelumab Cuts Severe Asthma Flares by 70% Across Diverse Patients

Single CAR T Infusion Clears Residual Disease in High-Risk Smoldering Myeloma Trial

Experimental Drug Elraglusib Extends Survival in Phase 2 Pancreatic Cancer Trial

Mouse Study Finds Semaglutide Directly Reprograms Liver Cells to Ease Disease Without Weight Loss

FDA Grants Accelerated Approval to Kresladi, First Gene Therapy for Severe Pediatric LAD-1

TIE2 Identified as Drug Target in Brain Cavernous Malformations After Mouse Study Stops New Lesions

Androgen Signaling Drives Lethal Pediatric Ependymoma, Study Finds

Brazil Moves to Bolster IP After Polylaminin Patent Lapse as First Safety Trial Nears

GSK to Acquire 35Pharma for $950 Million to Add Pulmonary Hypertension Candidate HS235

Oncolytic Viruses Trigger T‑Cell Infiltration and Survival Signals in Early Glioblastoma Trials

Randomized Trial Finds Solriamfetol Improves Alertness in Early-Morning Shift Workers

Low-Dose THC Paired With Celecoxib Improves Cognition and Alzheimer’s Pathology in Mice

Brazil Authorizes First Human Trial of UFRJ’s Polilaminina for Acute Spinal Cord Injury

Argentina Launches Lilly’s Mounjaro for Obesity and Diabetes After ANMAT Approval

Engineered Herpes Virus Shows Preclinical Gains Against Glioblastoma